Time course of the lymphopenia in BB rats. Relation to the onset of diabetes

Diabetes
|October 1, 1985
PubMed

Insights

Spontaneously diabetic BB rats exhibit early lymphopenia (low lymphocyte counts), affecting T-cell subsets. This genetically determined defect may predispose rats to diabetes development.

Area of Science:

  • Immunology
  • Endocrinology
  • Genetics

Background:

  • The BB rat syndrome, a model for Type 1 diabetes, is characterized by lymphopenia.
  • Lymphopenia may be a prerequisite for diabetes development in these rats.

Purpose of the Study:

  • To investigate the early time course of peripheral blood lymphocyte counts and subsets in BB rats from birth to 66 days.
  • To determine if lymphocyte subset changes predict diabetes onset.

Main Methods:

  • Peripheral blood lymphocyte counts and subsets (T-cells, helper/inducer, suppressor/cytotoxic, B-cells) were assessed from birth to 66 days of age.
  • Rats were monitored for diabetes onset.

Main Results:

  • At birth, total lymphocytes, T-cells (W3/13+, OX19+), helper/inducer (W3/25+), and suppressor/cytotoxic (OX8+) subsets were decreased.
  • Lymphocyte counts showed a subnormal rise over time.
  • No significant differences in lymphocyte counts at 66 days predicted subsequent diabetes development.
  • No concurrent changes in lymphocyte counts were observed at diabetes onset.

Conclusions:

  • A genetically determined defect in lymphocyte numbers exists in BB rats, leading to a lifelong subnormal lymphocyte count.
  • This defect may predispose rats to diabetes by interacting with an unidentified factor causing beta-cell cytotoxicity.

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.